TherapeuticsMD, Inc. Operating Leases, Rent Expense, Sublease Rentals
TherapeuticsMD, Inc. (TXMD) reported Operating Leases, Rent Expense, Sublease Rentals of $41.61 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2017-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseSubleaseRentals1 · last filed 2017-02-28
- TherapeuticsMD, Inc. operating leases, rent expense, sublease rentals for the quarter ending 2014-12-31 was -$387.00.
- TherapeuticsMD, Inc. operating leases, rent expense, sublease rentals for the quarter ending 2014-09-30 was $6.00K.
- TherapeuticsMD, Inc. operating leases, rent expense, sublease rentals for the quarter ending 2014-06-30 was $18.00K.
- TherapeuticsMD, Inc. operating leases, rent expense, sublease rentals for the quarter ending 2014-03-31 was $17.98K.
- TherapeuticsMD, Inc. operating leases, rent expense, sublease rentals for fiscal 2014 was $41.61K.
| Period end | Operating Leases, Rent Expense, Sublease Rentals 3 month | Operating Leases, Rent Expense, Sublease Rentals 3 month as first filed | Operating Leases, Rent Expense, Sublease Rentals 6 month | Operating Leases, Rent Expense, Sublease Rentals 6 month as first filed | Operating Leases, Rent Expense, Sublease Rentals 9 month | Operating Leases, Rent Expense, Sublease Rentals 9 month as first filed | Operating Leases, Rent Expense, Sublease Rentals 12 month |
|---|---|---|---|---|---|---|---|
| 2014-12-31 | -$387.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $5.61K derived: sum of 2 quarters · filed 2017-02-28 | $23.61K derived: sum of 3 quarters · filed 2017-02-28 | $41.61K 10-K · filed 2017-02-28 | |||
| 2014-09-30 | $6.00K 10-Q · filed 2015-11-05 | $5.99K 10-Q · filed 2014-11-07 | $24.00K derived: sum of 2 quarters · filed 2015-11-05 | $42.00K 10-Q · filed 2015-11-05 | $41.95K 10-Q · filed 2014-11-07 | ||
| 2014-06-30 | $18.00K 10-Q · filed 2015-08-07 | $36.00K 10-Q · filed 2015-08-07 | $35.96K 10-Q · filed 2014-08-07 | ||||
| 2014-03-31 | $17.98K 10-Q · filed 2015-05-07 | ||||||
| 2013-12-31 | $32.96K 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |